Taipei, Taiwan

Fan-Lun Liu

USPTO Granted Patents = 2 

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021-2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Fan-Lun Liu in Topical Formulations

Introduction

Fan-Lun Liu is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of topical treatments for autoimmune diseases. With a total of 2 patents, Liu's work has the potential to impact many patients suffering from these conditions.

Latest Patents

Liu's latest patents focus on topical formulations comprising tofacitinib. The first patent describes a formulation that includes a therapeutically effective amount of tofacitinib, at least one solvent, and optionally one or more other pharmaceutically acceptable excipients. This formulation aims to provide a method for treating and/or preventing autoimmune diseases in subjects. The second patent reiterates similar components and objectives, emphasizing the therapeutic potential of tofacitinib in topical applications.

Career Highlights

Throughout his career, Fan-Lun Liu has worked with various companies, including Twi Pharmaceuticals, Inc. and Twi Biotechnology, Inc. His experience in these organizations has allowed him to refine his expertise in pharmaceutical development and innovation.

Collaborations

Liu has collaborated with notable colleagues such as Chih-Ming Chen and Guang-Wei Lu. These partnerships have likely contributed to the advancement of his research and the successful development of his patents.

Conclusion

Fan-Lun Liu's contributions to the field of topical formulations represent a significant advancement in the treatment of autoimmune diseases. His innovative work continues to pave the way for new therapeutic options for patients in need.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…